Application 021640
- Type
- BLA
- Sponsor
- BAUSCH AND LOMB
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 021640 | Vitrase | hyaluronidase | 351(a) | Disc | 2026-09-01 |
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | VITRASE | HYALURONIDASE | INJECTABLE;INJECTION | 6,200 UNITS/VIAL | No | No |
| 002 | VITRASE | HYALURONIDASE | INJECTABLE;INJECTION | 200 UNITS/VIAL | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| HYLENEX Recombinant | HYALURONIDASE | Antares Pharma, Inc. | 3023cc56-ed4b-4e87-b3a1-81b20943f658 | 2024-11-11 | Warnings, Adverse reactions | HYALURONIDASE |
| AMPHADASE | HYALURONIDASE | Amphastar Pharmaceuticals, Inc. | 8396ea96-7cb5-4e26-87a4-90bca9c3c6dd | 2024-02-01 | Warnings, Adverse reactions | HYALURONIDASE |
| HYALURONIDASE | HYALURONIDASE | HF Acquisition Co LLC, DBA HealthFirst | c3f1db01-58bf-2226-e053-2a95a90a8b33 | 2021-06-04 | Warnings, Adverse reactions | HYALURONIDASE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 24208-002 | VITRASE | hyaluronidase, ovine | Bausch & Lomb Incorporated | BLA | Current |
| 24208-002 | VITRASE | hyaluronidase, ovine | Bausch & Lomb Incorporated | NDA | Current |
| 24208-002 | VITRASE | hyaluronidase, ovine | Bausch & Lomb Incorporated | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 77226 | SUPPL | 2024-01-16 |
| 77216 | SUPPL | 2024-01-16 |
| 62382 | APPL | 2020-03-31 |
| 54376 | SUPPL | 2020-03-23 |
| 54371 | SUPPL | 2020-03-23 |
| 44482 | ORIG | 2020-03-23 |
| 37380 | SUPPL | 2020-03-23 |
| 37379 | SUPPL | 2020-03-23 |
| 37378 | SUPPL | 2020-03-23 |
| 37377 | SUPPL | 2020-03-23 |
| 37376 | ORIG | 2020-03-23 |
| 28293 | SUPPL | 2020-03-23 |
| 28292 | SUPPL | 2020-03-23 |
| 28291 | SUPPL | 2020-03-23 |
| 28290 | ORIG | 2020-03-23 |
| 21764 | ORIG | 2020-03-23 |
| 5899 | SUPPL | 2020-03-23 |